134 related articles for article (PubMed ID: 7845668)
1. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes.
Theile M; Hartmann S; Scherthan H; Arnold W; Deppert W; Frege R; Glaab F; Haensch W; Scherneck S
Oncogene; 1995 Feb; 10(3):439-47. PubMed ID: 7845668
[TBL] [Abstract][Full Text] [Related]
2. Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25.
Plummer SJ; Adams L; Simmons JA; Casey G
Oncogene; 1997 May; 14(19):2339-45. PubMed ID: 9178910
[TBL] [Abstract][Full Text] [Related]
3. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
[TBL] [Abstract][Full Text] [Related]
4. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer.
Theile M; Seitz S; Arnold W; Jandrig B; Frege R; Schlag PM; Haensch W; Guski H; Winzer KJ; Barrett JC; Scherneck S
Oncogene; 1996 Aug; 13(4):677-85. PubMed ID: 8761288
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11.
Negrini M; Sabbioni S; Possati L; Rattan S; Corallini A; Barbanti-Brodano G; Croce CM
Cancer Res; 1994 Mar; 54(5):1331-6. PubMed ID: 8118824
[TBL] [Abstract][Full Text] [Related]
6. Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosomal region 17q.
Murakami YS; Brothman AR; Leach RJ; White RL
Cancer Res; 1995 Aug; 55(15):3389-94. PubMed ID: 7614477
[TBL] [Abstract][Full Text] [Related]
7. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
[TBL] [Abstract][Full Text] [Related]
8. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
[TBL] [Abstract][Full Text] [Related]
9. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
10. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.
Miele ME; Robertson G; Lee JH; Coleman A; McGary CT; Fisher PB; Lugo TG; Welch DR
Mol Carcinog; 1996 Apr; 15(4):284-99. PubMed ID: 8634087
[TBL] [Abstract][Full Text] [Related]
11. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
[TBL] [Abstract][Full Text] [Related]
12. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
13. Mutations of the BRCA1 gene in human cancer.
Xu CF; Solomon E
Semin Cancer Biol; 1996 Feb; 7(1):33-40. PubMed ID: 8695765
[TBL] [Abstract][Full Text] [Related]
14. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11.
Phillips KK; Welch DR; Miele ME; Lee JH; Wei LL; Weissman BE
Cancer Res; 1996 Mar; 56(6):1222-7. PubMed ID: 8640802
[TBL] [Abstract][Full Text] [Related]
15. A malignant melanoma tumor suppressor on human chromosome 11.
Robertson G; Coleman A; Lugo TG
Cancer Res; 1996 Oct; 56(19):4487-92. PubMed ID: 8813145
[TBL] [Abstract][Full Text] [Related]
16. The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice.
Vijayakumar S; Garcia D; Hensel CH; Banerjee M; Bracht T; Xiang R; Kagan J; Naylor SL
Genes Chromosomes Cancer; 2005 Dec; 44(4):365-72. PubMed ID: 16080199
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer.
Williams BJ; Jones E; Zhu XL; Steele MR; Stephenson RA; Rohr LR; Brothman AR
J Urol; 1996 Feb; 155(2):720-5. PubMed ID: 8558713
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
19. Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line CAL51.
Klebig C; Seitz S; Korsching E; Kristiansen G; Gustavus D; Scherneck S; Petersen I
Genes Chromosomes Cancer; 2005 Nov; 44(3):233-46. PubMed ID: 16049915
[TBL] [Abstract][Full Text] [Related]
20. Suppression of tumorigenicity of rat liver tumor cells by human chromosome 13: evidence against the involvement of pRb and BRCA2.
Rider MA; Butz GM; Ricketts SL; Newberry ST; Grisham JW; Coleman WB
Int J Oncol; 2002 Feb; 20(2):235-45. PubMed ID: 11788883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
